These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 25976647)

  • 21. Secondary outcomes in a clinical trial of carotenoids with coantioxidants versus placebo in early age-related macular degeneration.
    Beatty S; Chakravarthy U; Nolan JM; Muldrew KA; Woodside JV; Denny F; Stevenson MR
    Ophthalmology; 2013 Mar; 120(3):600-606. PubMed ID: 23218821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum response to supplemental macular carotenoids in subjects with and without age-related macular degeneration.
    Meagher KA; Thurnham DI; Beatty S; Howard AN; Connolly E; Cummins W; Nolan JM
    Br J Nutr; 2013 Jul; 110(2):289-300. PubMed ID: 23211762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum and macular response to carotenoid-enriched egg supplementation in human subjects: the Egg Xanthophyll Intervention clinical Trial (EXIT).
    Kelly D; Nolan JM; Howard AN; Stack J; Akuffo KO; Moran R; Thurnham DI; Dennison J; Meagher KA; Beatty S
    Br J Nutr; 2017 Jan; 117(1):108-123. PubMed ID: 28122649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carotenoids in Age-related Maculopathy Italian Study (CARMIS): two-year results of a randomized study.
    Piermarocchi S; Saviano S; Parisi V; Tedeschi M; Panozzo G; Scarpa G; Boschi G; Lo Giudice G;
    Eur J Ophthalmol; 2012; 22(2):216-25. PubMed ID: 22009916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes following supplementation with lutein and zeaxanthin in retinal function in eyes with early age-related macular degeneration: a randomised, double-blind, placebo-controlled trial.
    Huang YM; Dou HL; Huang FF; Xu XR; Zou ZY; Lu XR; Lin XM
    Br J Ophthalmol; 2015 Mar; 99(3):371-5. PubMed ID: 25228440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluorescence lifetime imaging ophthalmoscopy and the influence of oral lutein/zeaxanthin supplementation on macular pigment (FLOS) - A pilot study.
    Jaggi D; Solberg Y; Dysli C; Lincke J; Habra O; Wyss A; Wolf S; Zinkernagel M
    Clin Nutr ESPEN; 2023 Aug; 56():127-134. PubMed ID: 37344061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of macular pigment augmentation on visual performance using different carotenoid formulations.
    Loughman J; Nolan JM; Howard AN; Connolly E; Meagher K; Beatty S
    Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7871-80. PubMed ID: 23132800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Macular Pigment Response to Lutein, Zeaxanthin, and Meso-zeaxanthin Supplementation in Open-Angle Glaucoma: A Randomized Controlled Trial.
    Loughman J; Loskutova E; Butler JS; Siah WF; O'Brien C
    Ophthalmol Sci; 2021 Sep; 1(3):100039. PubMed ID: 36247822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macular pigment density variation after supplementation of lutein and zeaxanthin using the Visucam
    Azar G; Quaranta-El Maftouhi M; Masella JJ; Mauget-Faÿsse M
    J Fr Ophtalmol; 2017 Apr; 40(4):303-313. PubMed ID: 28336284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lutein and zeaxanthin supplementation and association with visual function in age-related macular degeneration.
    Liu R; Wang T; Zhang B; Qin L; Wu C; Li Q; Ma L
    Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):252-8. PubMed ID: 25515572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pilot evaluation of short-term changes in macular pigment and retinal sensitivity in different phenotypes of early age-related macular degeneration after carotenoid supplementation.
    Corvi F; Souied EH; Falfoul Y; Georges A; Jung C; Querques L; Querques G
    Br J Ophthalmol; 2017 Jun; 101(6):770-773. PubMed ID: 27587715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-Dietary Correlates and Determinants of Plasma Lutein and Zeaxanthin Concentrations in the Irish Population.
    Moran R; Nolan JM; Stack J; O'Halloran AM; Feeney J; Akuffo KO; Kenny RA; Beatty S
    J Nutr Health Aging; 2017; 21(3):254-261. PubMed ID: 28244563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18.
    van Asten F; Chiu CY; Agrón E; Clemons TE; Ratnapriya R; Swaroop A; Klein ML; Fan R; Chew EY;
    Ophthalmology; 2019 Nov; 126(11):1541-1548. PubMed ID: 31358387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Dietary Supplementation With Lutein, Zeaxanthin, and ω-3 on Macular Pigment: A Randomized Clinical Trial.
    Korobelnik JF; Rougier MB; Delyfer MN; Bron A; Merle BMJ; Savel H; Chêne G; Delcourt C; Creuzot-Garcher C
    JAMA Ophthalmol; 2017 Nov; 135(11):1259-1266. PubMed ID: 28973076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Supplemental Retinal Carotenoids Enhance Memory in Healthy Individuals with Low Levels of Macular Pigment in A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Power R; Coen RF; Beatty S; Mulcahy R; Moran R; Stack J; Howard AN; Nolan JM
    J Alzheimers Dis; 2018; 61(3):947-961. PubMed ID: 29332050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A double-blind, placebo-controlled study on the effects of lutein and zeaxanthin on photostress recovery, glare disability, and chromatic contrast.
    Hammond BR; Fletcher LM; Roos F; Wittwer J; Schalch W
    Invest Ophthalmol Vis Sci; 2014 Dec; 55(12):8583-9. PubMed ID: 25468896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in Macular Pigment Optical Density and Serum Lutein Concentration in Japanese Subjects Taking Two Different Lutein Supplements.
    Obana A; Tanito M; Gohto Y; Okazaki S; Gellermann W; Bernstein PS
    PLoS One; 2015; 10(10):e0139257. PubMed ID: 26451726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The heritability of macular response to supplemental lutein and zeaxanthin: a classic twin study.
    Hammond CJ; Liew SH; Van Kuijk FJ; Beatty S; Nolan JM; Spector TD; Gilbert CE
    Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4963-8. PubMed ID: 22700713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between macular pigment and visual function in subjects with early age-related macular degeneration.
    Akuffo KO; Nolan JM; Peto T; Stack J; Leung I; Corcoran L; Beatty S
    Br J Ophthalmol; 2017 Feb; 101(2):190-197. PubMed ID: 27091854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
    Age-Related Eye Disease Study 2 Research Group
    JAMA; 2013 May; 309(19):2005-15. PubMed ID: 23644932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.